Can we accurately classify schizophrenia patients from healthy controls using magnetic resonance imaging and machine learning?:A multi-method and multi-dataset study by Winterburn, Julie L et al.
                             Elsevier Editorial System(tm) for 
Schizophrenia Research 
                                  Manuscript Draft 
 
 
Manuscript Number: SCHRES-D-17-00102R1 
 
Title: Can we accurately classify schizophrenia patients from healthy 
controls using magnetic resonance imaging and machine learning? A multi-
method and multi-dataset study.  
 
Article Type: Full Length Article 
 
Keywords: structural magnetic resonance imaging, machine learning, 




Corresponding Author: Ms. Julie L Winterburn,  
 
Corresponding Author's Institution: Kimel Family Translational Imaging 
Genetics Research Laboratory, Research Imaging Centre, Centre for 
Addiction and Mental Health 
 
First Author: Julie L Winterburn 
 
Order of Authors: Julie L Winterburn; Aristotle N Voineskos; Gabriel A 
Devenyi; Eric Plitman; Camilo de la Fuente-Sandoval; Nikhil Bhagwat; 
Ariel Graff; Jo Knight; M. Mallar Chakravarty 
 
Abstract: Machine learning is a powerful tool that has previously been 
used to classify schizophrenia (SZ) patients from healthy controls (HC) 
using magnetic resonance images. Each study, however, uses different 
datasets, classification algorithms, and validation techniques. Here, we 
perform a critical appraisal of the accuracy of machine learning 
methodologies used in SZ/HC classifications studies by comparing three 
machine learning algorithms (logistic regression [LR], support vector 
machines [SVMs], and linear discriminant analysis [LDA]) on three 
independent datasets (435 subjects total) using two tissue density 
estimates and cortical thickness (CT). Performance is assessed using 10-
fold cross-validation, as well as a held-out validation set. 
Classification using CT outperformed tissue densities, but there was no 
clear effect of dataset. LR, SVMs, and LDA each yielded the highest 
accuracies for a different feature set and validation paradigm, but most 
accuracies were between 55-70%, well below previously reported values. 
The highest accuracy achieved was 73.5% using CT data and an SVM. Taken 
together, these results illustrate some of the obstacles to constructing 
effective disease classifiers, and suggest that tissue densities and CT 
may not be sufficiently sensitive for SZ/HC classification given current 






Can we accurately classify schizophrenia patients from healthy 
controls using magnetic resonance imaging and machine learning? 
A multi-method and multi-dataset study.  
Running title: Comparison of classification methods for schizophrenia in MRI 
 
Julie L. Winterburna,b,c, Aristotle N. Voineskosc,d,e,f, Gabriel A. Devenyia, Eric Plitman6,7, 
Camilo de la Fuente-Sandovalh,i, Nikhil Bhagwata,b,c, Ariel Graffd,e,f,g, Jo Knighte,f,j, M. 
Mallar Chakravartya,b,k,l 
 
aComputational Brain Anatomy Laboratory, Douglas Mental Health Institute, McGill 
University, Montreal, Quebec, Canada 
bInstitute of Biomaterials and Biomedical Engineering, University of Toronto, Toronto, 
Ontario, Canada 
cKimel Family Translational Imaging-Genetics Research Lab, Research Imaging Centre, 
Campbell Family Mental Health Research Institute, Centre for Addiction and Mental 
Health, Toronto, Ontario, Canada 
dGeriatric Mental Health Division, Centre for Addiction and Mental Health, Toronto, 
Ontario, Canada 
eDepartment of Psychiatry, University of Toronto, Toronto, Ontario, Canada 
fInstitute of Medical Science, University of Toronto, Toronto, Ontario, Canada 
gMultimodal Imaging Group, Research Imaging Centre, Centre for Addiction and Mental 
Health, Toronto, Ontario, Canada 
hLaboratory of Experimental Psychiatry, Instituto Nacional de Neurología y 
Neurocirugía, Mexico City, Mexico  
hNeuropsychiatry Department, Instituto Nacional de Neurología y Neurocirugía, Mexico 
City, Mexico 
jBiostatistics Division, Dalla Lana School of Public Health, University of Toronto, 
Toronto, Ontario, Canada 
kDepartments of Psychiatry and Biomedical Engineering, McGill University, Montreal, 
Quebec, Canada 
lBiological and Biomedical Engineering, McGill University, Montreal, Quebec, Canada 
 
 
Correspondence should be addressed to:  
Julie Winterburn: winterburn.julie@gmail.com, +1 (647) 466-4802 
OR Mallar Chakravarty: mallar@cobralab.ca 
Computational Brain Anatomy Laboratory  
Brain Imaging Centre, Douglas Mental Health University Institute 
6875 Boulevard LaSalle 










Machine learning is a powerful tool that has previously been used to classify 
schizophrenia (SZ) patients from healthy controls (HC) using magnetic resonance 
images. Each study, however, uses different datasets, classification algorithms, and 
validation techniques. Here, we perform a critical appraisal of the accuracy of machine 
learning methodologies used in SZ/HC classifications studies by comparing three 
machine learning algorithms (logistic regression [LR], support vector machines [SVMs], 
and linear discriminant analysis [LDA]) on three independent datasets (435 subjects total) 
using two tissue density estimates and cortical thickness (CT). Performance is assessed 
using 10-fold cross-validation, as well as a held-out validation set. Classification using 
CT outperformed tissue densities, but there was no clear effect of dataset. LR, SVMs, and 
LDA each yielded the highest accuracies for a different feature set and validation 
paradigm, but most accuracies were between 55-70%, well below previously reported 
values. The highest accuracy achieved was 73.5% using CT data and an SVM. Taken 
together, these results illustrate some of the obstacles to constructing effective disease 
classifiers, and suggest that tissue densities and CT may not be sufficiently sensitive for 
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Schizophrenia (SZ) and related psychoses are typically diagnosed using criteria defined 
in the 5th edition of The Diagnostic and Statistical Manual of Mental Disorders 
(American Psychiatric Association, 2013). However, the etiology of SZ is poorly 
understood (American Psychiatric Association, 2013; Demirci and Calhoun, 2009; Kim 
et al., 2015). While differences among brain regions have been consistently observed in 
univariate analyses at the group level (Csernansky et al., 2002; Gaser et al., 2004; Narr et 
al., 2005), these differences cannot be used for automated, patient-by-patient, 
biologically-defined diagnosis. To this end, studies have recently explored the diagnostic 
value of magnetic resonance (MR) imaging data (Davatzikos et al., 2005) in combination 
with machine learning, a field of computer science that uses pattern recognition for 
classification and predictive tasks (Kambeitz et al., 2015; Zarogianni et al., 2013).  
These machine learning studies in SZ can be difficult to compare to one another due to 
differences in study populations, data processing steps, classification algorithms, and 
validation techniques. This heterogeneity was recently highlighted in a study that 
surveyed 38 publications that applied machine learning to SZ classification (Kambeitz et 
al., 2015). The 18 studies from this review that used structural MRI data are highlighted 
in Table 1 (along with sample characteristics, choice of inputs, methodology, and 
validation techniques).  
We have performed a comprehensive comparison of machine learning techniques and 
methods used in SZ classification. Our evaluation included the most frequently-used 
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classifiers (linear discriminant analysis and linear and non-linear support vector 
machines), one less common one (logistic regression), and a popular publicly-available 
method (COMPARE (Fan et al., 2007)) across three independent datasets (435 subjects 
acquired at 1.5T and 3T) of both first-episode and chronic patients. We also used three 
MR-derived metrics including voxel based morphometry (VBM) (Ashburner and Friston, 
2000), RAVENS maps (Davatzikos et al., 2001), and cortical thickness measures (Lerch 
and Evans, 2005) yielding a total of 42 comparisons (summarized in Table 2). Finally, we 
assessed the impact of two different validation methods on generalizability: 10-fold 
cross-validation, and a held-out dataset. To the best of our knowledge, this study is the 
most expansive and systematic on this topic to date.  
2 Materials and Methods 
2.1 Datasets Evaluated 
Classification performance was evaluated on three independently-collected datasets, all 
of which have been published previously. For descriptions and demographics, see Table 3 
and Supplementary Materials and Methods Section 1. 
1. Centre for Addiction and Mental Health (CAMH) (Voineskos et al., 2011; 
Wheeler et al., 2013).  
2. Northwestern University Schizophrenia Data and Software Tool (NUSDAST) 
(Wang et al., 2013).  
3. National Institute of Neurology and Neurosurgery (INNN) (de la Fuente-Sandoval 
et al., 2011, 2013; Plitman et al., 2015).  
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2.2 Image Processing 
Three neuroanatomical metrics were selected based on their prevalence in previous 
studies (Table 1). Further information can be found in Supplementary Materials 
and Methods Section 2.  
1) Modulated GM VBM (Ashburner and Friston, 2000; Karageorgiou et al., 2011; 
Nieuwenhuis et al., 2012; Schnack et al., 2013). Briefly, this is a voxel-wise estimate 
of the local density of GM in a given voxel region.  
2) GM RAVENS maps (Davatzikos et al., 2001; Fan et al., 2007; Zanetti et al., 2013). 
A RAVENS map is a metric similar to modulated VBM, but is derived using a 
different method for computing local GM density. RAVENS maps are calculated 
using an open-source software package (Davatzikos et al., 2001). 
3) Cortical thickness (Lerch and Evans, 2005; Takayanagi et al., 2011; Yoon et al., 
2007). This metric measures the thickness of the GM cortical mantle at ~80,000 
vertices across the brain.  
2.3 Machine Learning Analyses 
All analyses were performed using R (www.R-project.org) (R Core Team, 2013). 
Following the work of previous studies (Borgwardt et al., 2010; Karageorgiou et al., 
2011; Kasparek et al., 2011; Santos et al., 2010), a Principal Component Analysis (PCA) 
was applied to reduce dimensionality; only those PCs explaining >1% of the input feature 
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variance were retained (Liu et al., 2012) Table S1 contains a breakdown of the PCs. 
Classification methods and parameter optimization are described in greater detail 
in Supplementary Materials and Methods Section 3. The following algorithms were 
explored: 
x Logistic Regression (LR) uses continuous independent variables to describe a 
single dependent categorical variable. To avoid over-fitting, elastic net 
regularization (a combination of LASSO and ridge regression) were added to the 
models.  
x Support Vector Machines (SVMs) distinguish two distinct classes by 
constructing a hyperplane between the classes using the most ambiguous 
datapoints. The performances of both linear and radial basis function (RBF; ie: 
non-linear) kernels were assessed.  
x Linear Discriminant Analysis (LDA) performs classification based on 
continuous variables, and maps input features to a lower dimensional space using 
a linear transformation. In this space, between-class variance is maximized, and 
within-class variance is minimized.  
x COMPARE is a software tool that combines feature reduction techniques with an 
SVM-based classifier (RBF kernel) to perform classifications based on tissue 




Two validation methods were compared: 10-fold cross-validation and classification on a 
previously “unseen” and held-out subset of each sample (Figure 1). The data were first 
split randomly (SZ:HC ratio retained) into two subsets (2:1 ratio), which we will 
refer to henceforth as the ‘training’ and ‘validation’ sets. PCA-based dimensionality 
reduction was applied to the full training set, and then the validation dataset was 
projected onto this PC space to ensure consistency in the features between datasets. 
To assist with parameter tuning and to allow for comparison with multiple 
validation methods, we performed 10-fold cross-validation in the training set and 
report the performance. We then applied our trained models to the validation set 
(the 1/3rd of the data that had been held out) to get an estimation of performance on 
an unseen dataset. Algorithm accuracy (percentage of correctly-classified subjects) 
averaged across folds is reported for the training set, while accuracy, sensitivity, and 
specificity are reported for the validation set. Given that our data had only one of two 
possible classes (HC or SZ), the significance of each accuracy result was assessed 




All training set results (using 10-fold cross-validation) are summarized in Table 4. 
Results from the held-out subset are summarized in Table 5. Further details are provided 
in the Supplementary Materials and Methods.  
3.1 Modulated VBM demonstrates poor accuracy 
Results using modulated VBM demonstrate poor accuracy through 10-fold cross-
validation (<65% throughout) (Table 4). Non-linear SVMs offer the highest performance 
(mean accuracy of 63.2% across the three datasets versus 59.8% mean accuracy for LR, 
55.1% for linear SVM, and 57.7% for LDA). The pairing of non-linear SVMs and 
modulated VBM consistently performed the best within each dataset (accuracies 61.7-
64.2%; best performance in NUSDAST dataset). In all cases, performance is better than 
chance based on a binomial probability statistic, with the exception of the linear SVM 
applied to the INNN and NUSDAST datasets.  
The validation results (Table 5) are on par with the training results for most algorithms. 
In the cases of LR and linear SVM, validation set accuracy exceeds 10-fold training 
accuracy in almost all cases, with the biggest gain in the NUSDAST data set (e.g.: LR 
training: 57.4%; LR validation: 65.2%). However, when using a non-linear SVM, the 
accuracy observed for the validation set is notably lower than the training set for both 
NUSDAST (training: 64.2%; validation: 56.5%) and INNN (training: 63.8%; validation: 
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59.4%). Similarly, NUSDAST accuracy improves with the use of LDA in the validation 
set over the training set (training: 56.4%; validation: 63.0%). Nonetheless, based on the 
performance in the validation phase, no single method outperformed the others. There is 
no fixed trend for sensitivity and specificity performance; however, a number of the 
models selectively show very poor sensitivity and specificity (<50% for most trials in the 
CAMH dataset). Conversely, other models demonstrate exceedingly high sensitivity at 
the expense of very low specificity (NUSDAST dataset). Only those methods with >60% 
accuracy in the CAMH and NUSDAST datasets performed better than chance for 
validation.  
3.2 Performance with RAVENS is not better than 
modulated VBM 
As with modulated VBM, the use of RAVENS maps demonstrates poor accuracy across 
all datasets and algorithm types. Within the training data (Table 4), LR performed the 
best for the NUSDAST and INNN datasets (66.0% and 70.0%; respectively), while non-
linear SVM performs the best for the CAMH dataset (63.3%). Across methods, LR was 
also the best performer (mean accuracy of 65.6% versus 60.1% for linear SVM, 62.0% 
for non-linear SVM, and 57.6% for LDA). Regardless, there was no discernable impact 
of datasets on performance. Almost all of the training algorithms performed better than 
chance, except for linear SVM and LDA in the CAMH and INNN datasets, respectively. 
Within the validation dataset (Table 5), the RAVENS accuracies do not seriously over- or 
under-perform compared to the training data. Overall, the accuracies were slightly higher 
than the modulated VBM results (61.4% versus 59.9%). LDA in the CAMH dataset 
(69.5%) and linear SVM in the NUSDAST dataset (69.6%) outperformed all other 
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methods. In general, LDA outperformed all other methods with 65.7% accuracy averaged 
across the three datasets (compared to 61.7% for LR, 58.5% for linear SVM, and 59.8% 
for non-linear SVM). None of the datasets notably outperformed the others. Only seven 
of the twelve methods performed better than chance.  
Sensitivity and specificity results were very similar to the observations made using 
modulated VBM. Some models show very poor sensitivity (<50% for most trials in the 
CAMH dataset as with modulated VBM) and specificity, while other models 
demonstrated exceedingly high sensitivity at the expense of very low specificity 
(NUSDAST dataset, as with modulated VBM).  
3.3 Cortical thickness offers improved accuracy, specificity, 
and sensitivity 
Compared to both modulated VBM and RAVENS, the use of cortical thickness as an 
input improves many of the classification results within the training set (Table 4). In this 
particular case we see that many of the accuracies trend towards or exceed 70% 
(nonlinear SVM with CAMH: 68.0%; LR, linear SVM, and nonlinear SVM with 
NUSDAST: 68.8%, 71.9%, and 68.8% respectively). However, the group with the 
smallest sample size, INNN, did not achieve these accuracies. Non-linear SVMs 
outperformed all other methods in the training data (67.0% mean accuracy versus 59.1% 
for LR, 64.2% for linear SVM, and 59.6% for LDA). In this particular case there is a 
clear effect of the dataset used, where NUSDAST dataset yields observably better results 
overall, with a mean accuracy of 68.8% across the four algorithms (compared with 58.6% 
for CAMH and 60.0% for INNN). All training sets performed better than chance except 
for LR in CAMH and INNN datasets.  
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In the validation phase, many improvements in classification accuracy are observed 
relative to the two tissue density metrics (Table 5). Similar to the training phase, many of 
the methods trend towards or exceed 70% classification accuracy. The best performance 
was observed using nonlinear SVM in the INNN dataset, with an accuracy of 73.5% 
(CAMH with LDA: 68.3%; NUSDAST with LR, linear SVM, and nonlinear SVM: 70.8, 
68.1, and 70.8%, respectively; LR for INNN: 69.7%). LR outperformed all other methods 
in the validation set, with 66.9% mean accuracy across the three datasets (compared with 
62.9% for linear SVM, 63.7% for non-linear SVM, and 63.9% for LDA). The NUSDAST 
dataset performed better overall across the four algorithms, with 68.1% mean accuracy 
(compared with 63.5% for CAMH and 61.5% for INNN). Similar to the modulated VBM 
data, a number of the models show very poor (<50%) sensitivity, mostly with the CAMH 
dataset. However, this trend is not nearly as prevalent as observed with modulated VBM 
and RAVENS maps. All models performed better than chance except linear SVM and 
LDA using the INNN dataset.  
3.4 Using COMPARE improves classification accuracy 
using modulated VBM 
The input, training, and validation datasets used with the COMPARE algorithm were 
identical to those used for the modulated VBM analyses. On the training sets, 
COMPARE performed with an overall accuracy of 63.3%, 71.3%, and 71.2% on the 
CAMH, NUSDAST, and INNN datasets, respectively (Table 4). These accuracies were 
higher than any of the other methods using modulated VBM in training. On the validation 
set, the performance was 55.9%, 61.0%, and 67.7% for the CAMH, NUSDAST, and 
INNN datasets, respectively (Table 5). These results are similar to the non-COMPARE 
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validation results. However, the accuracy for INNN is better than what was observed in 
any of the validation results for modulated VBM (maximum accuracy 65.2% with LR). 
All results were statistically greater than chance except for the validation subset of the 
CAMH data.  
The subjects selected for inclusion, training, and testing in the RAVENS COMPARE 
analysis were the same as those used in the modulated VBM analysis. With RAVENS 
inputs, COMPARE achieved surprisingly low overall accuracies of 55.8%, 50.0%, and 
50.0% in the training set, and 51.2%, 51.0%, and 50.6% in the validation set for the 
CAMH, NUSDAST, and INNN datasets, respectively. Only the CAMH training data 




The effectiveness of machine learning algorithms commonly used in the literature for 
classifying patients with SZ from HC were compared on three independent datasets using 
cortical thickness and two estimates of tissue density, and validated using three different 
techniques. The performance of all algorithms on all datasets was poor relative to 
previously reported results; however algorithms constructed using cortical thickness 
generally outperformed the others. Non-linear SVMs marginally outperformed the other 
methods using 10-fold cross-validation with modulated VBM and cortical thickness. LR 
was slightly superior to the other methods using a left-out validation dataset with both 
modulated VBM and cortical thickness, with a maximum accuracy of 70.8% for cortical 
thickness in the NUSDAST dataset. The best algorithms using RAVENS maps were LR 
in the training set and LDA in the validation set. The best result overall was 73.5% in the 
INNN validation subset using a non-linear SVM and cortical thickness.  
No single dataset consistently over- or under-performed relative to the other two, 
although the NUSDAST dataset performed the best of the three datasets when using 
cortical thickness data, which turned out to be the most effective discriminatory 
metric used in this study. This result is not trivial to explain, as the datasets differ in 
multiple ways, including: primary diagnosis of the patient group, illness duration 
and severity, sample size, and the MR field strength used to acquire the images 
(Table 3). Additionally, the NUSDAST dataset is neither the smallest nor the largest 
of the datasets used in this study, and its patient population is not well-characterized 
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in its original publication (only an general diagnosis of schizophrenia is provided). It 
could be that this was the most homogeneous of the three datasets (in terms of 
illness duration, illness severity, medication status), and thus classification into two 
distinct groups was the most straight-forward.  
In general, the diagnoses present across the three datasets are heterogeneous. The 
CAMH dataset contains subjects with both schizophrenia and schizoaffective 
disorder; as mentioned, the subjects in the NUSDAST dataset are not characterized 
diagnostically beyond schizophrenia/control; and the INNN subjects all have non-
affective psychosis (either brief psychotic disorder, schizophreniform disorder, or 
schizophrenia). To explore if the heterogeneity of the samples was causing our low 
accuracies, we reanalyzed the CAMH VBM dataset with the schizoaffective subjects 
(n=26) excluded. Accuracies in this non-affective subset were even lower (<54% for 
all algorithms). Therefore it is unclear if the clinical heterogeneity is affecting the 
accuracies. Given the enforced homogeneity of the INNN dataset (early in disease 
course, unmedicated), as well as the high symptom severity (relative to the CAMH 
dataset, as measured using the Positive and Negative Syndrome Scale (Kay et al., 
1987)), we expected the clearest differentiation between patient and control groups 
compared with the CAMH and NUSDAST datasets. This, however, was not what we 
observed. It may be that this population was composed of patients so early in their 
disease course that they were not yet correctly diagnosed. More likely, the well-
documented effects of medication on neuroanatomy actually aid classification, as 
they further differentiate patient and control groups beyond the subtle natural 
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differences in their neuroanatomy (Ho et al., 2011). The effect of medication on 
classification performance merits significant further study.  
We acknowledge that many of our results are difficult to explain and may seem a bit 
atypical. We believe our results illustrate that, contrary to existing results in the 
literature, reliable and versatile SZ/HC classifiers are difficult to construct, and 
existing classifiers in the literature may be over-estimating performance.  
To the best of our ability we attempted to replicate the methodologies used in previous 
studies (Table 1). The accuracies we observed are considerably lower than what others 
report. Specifically, studies using SVMs with an RBF kernel trained on tissue densities 
report accuracies between 81.1% and 91.8%, compared with 55.4% - 66.1% achieved 
here (Davatzikos et al., 2005; Fan et al., 2007; Zanetti et al., 2013). Likewise, accuracies 
of 71.4% have been reported using linear SVMs (Nieuwenhuis et al., 2012), compared 
with 51.9% - 65.6% in this study; and 86.1% using LR (Sun et al., 2009), compared with 
56.3% - 67.8%. The cortical thickness results were also lower than what has been 
previously reported (Yoon et al., 2007). Many of these studies, however, have small 
sample sizes (<36 subjects/group) (Fan et al., 2007; Karageorgiou et al., 2011; Sun et al., 
2009), which may limit their results. Additionally, many of the studies use LOOCV, and 
do not validate the model on a held-out dataset. The results from the COMPARE analysis 
were not as high as those initially recorded by Fan and colleagues (Fan et al., 2007). A 
similar result was reported by Zanetti and colleagues (Zanetti et al., 2013), and they 
postulated that it was likely due to the forced homogeneity of the dataset used in the Fan 
study, which does not reflect the ‘real-word’ heterogeneity of a patient population. It has 
been proposed that an SVM classifier with an RBF kernel is not applicable for very high-
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dimensional feature sets, and under certain conditions can lead to severe underfitting 
(subjects are all assigned to the majority class) or overfitting (Keerthi and Lin, 2006). 
Underfitting may have been an issue in our datasets, as the sensitivity and specificity 
results suggest that classifications were sometimes driven by overclassifying a specific 
group (ie: the most stable results may have come from classifying a disproportionate 
number of individuals as SZ or HC). It is possible that this effect could be corrected using 
a weighting term, and this should be explored in future studies. Classification studies 
have also been performed using other imaging modalities. A recent study reviewed 
methods for multivariate analysis in functional MRI (Pereira et al., 2009). Much like 
our study, they were not able to conclude that one particular combination of data 
processing and algorithm was optimal; however hopefully this type of work will set 
a precedent for future systematic studies across imaging modalities.  
It is interesting that we had difficulty replicating the findings of previous manuscripts 
given that our samples are on par with or substantially larger than samples previously 
used in the literature (Fan et al., 2007; Sun et al., 2009; Yoon et al., 2007; Zanetti et al., 
2013). In support of this, there is literature that suggests that larger samples may in 
fact be problematic (Schnack and Kahn, 2016). Smaller studies typically have more 
tightly-controlled exclusion criteria, and therefore are often more homogeneous. As 
sample sizes grow, so does the heterogeneity of the sample. This may have the 
somewhat counter-intuitive and unexpected effect of decreasing performance as 
sample size increases.  
Leave-one-out cross-validation (LOOCV) is used throughout the SZ classification 
literature, although it has been criticized due to its tendency to over-fit data and 
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provide an inconsistent estimate of the true model (Shao, 1993). LOOCV was 
performed in the training set of only the best performing dataset and metric 
combination to illustrate the possibility of overfitting. Given this tendency of LOOCV 
to over-estimate generalizability, we expected to see higher estimates of accuracy from 
the LOOCV experiments, although this was only observed in the non-linear SVM case 
(69.8% LOOCV accuracy versus 68.8% using 10-fold cross-validation). For all 
algorithms, the LOOCV-derived models performed worse on the left-out dataset than the 
models derived from 10-fold cross-validation, which supports the hypothesis that 
LOOCV is prone to over-fitting in the training dataset, and does not always create the 
best model for unseen data.  
Given the above factors, it is difficult to conclude that there is an optimal combination of 
image preprocessing, training, testing, and machine learning methods. However, we 
propose that cortical thickness inputs, when paired with LR or SVM, appear to provide 
the most robust estimates across datasets and methods. Further, we propose the use of 10-
fold cross validation and testing on an “unseen” dataset may be critical to buffer against 
over-fitting models and to provide robust estimates of classification accuracy, sensitivity, 
and specificity. Larger datasets may also help to understand the behaviour of all 
permutations within the methodologies tested. It would have been prohibitive to assess 
all possible variables that contribute to algorithm performance and conduct a fully 
controlled study where all variables are independent. We endeavored in this study, 
however, to shed some light on possible major contributing factors. Significant 
future work is needed to tease out in more detail the specific main effects and 
interactions. 
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Although the sample sizes of our three datasets compare favourably with previous 
studies, a limitation in our study (and in most machine learning studies in neuroimaging) 
is the number of subjects we had available to us. This meant that the number of subjects 
we included was much lower than the number of variables we used. Increasing sample 
size may improve the reliability of our results, or perhaps better expose the limitations of 
dimensionality reduction, training, and machine learning methods. Some of our results 
showed high sensitivity at the expense of low specificity. With a larger sample size, 
this could be mitigated by preserving the patient:control ratio within all folds of the 
10-fold cross-validation. Additionally, the number of features available from an MR 
image is enormous, and overfitting can be an issue with such large feature spaces. In 
order to manage this amount of data, some sort of dimensionality reduction must be 
performed, whether it be selecting a limited number of regions-of-interest (Greenstein, 
Malley, Weisinger, Clasen, & Gogtay, 2012; Nakamura et al., 2004; Ota et al., 2012; 
Pettersson-Yeo et al., 2013; Takayanagi et al., 2010, 2011; Yushkevich et al., 2005), 
image downsampling (Davatzikos et al., 2005; Nieuwenhuis et al., 2012), a PCA 
(Kasparek et al., 2011; Santos et al., 2010), an entirely novel method, (Fan et al., 2007; 
Zanetti et al., 2013), or some combination of thereof (Borgwardt et al., 2010; 
Karageorgiou et al., 2011; Nieuwenhuis et al., 2012). With improved computational 
power, it may be possible to retain all variables, and capture more of the subtle variability 
that exists between the brains of SZ patients and HC.  
We used a binomial probability statistic, which indicates how likely a given result is 
assuming the data follows a binomial distribution, to assess how meaningful our 
accuracy results were. Another method for assessing this is permutation testing, 
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which although more computationally expensive, is more generalizable as it does not 
assume an inherent probability distribution. Additionally, it may be more suitable 
to classification studies that use cross-validation (Noirhomme et al., 2014). In our 
case, since our data is non-random and can only be assigned to one of two classes, 
the binomial probability test was sufficient; however, the possible benefits of 
permutation testing should be explored in future studies. 
In conclusion, this study illustrates some of the limitations of applying machine learning 
to neuroimaging data, and suggests that perhaps cortical thickness and tissue densities are 
not reliable features for distinguishing between SZ and HC groups on a patient-by-patient 
basis using these methods. It is always tempting to adjust datasets and algorithms to boost 
accuracy after seeing the final results, but in this study, we endeavored to estimate the 
true discriminative ability of the algorithms, and limit data pre-processing and tailoring. 
Along with future, more extensive studies, the results from this study can be used to 
construct guidelines (such as most discriminative feature type, data preprocessing steps, 
dimensionality reduction, model selection, and training/validation paradigm) for 
performing classifications on novel datasets, which holds the promise of a clinical 
application supplementing symptom-based diagnoses. 
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 Figure 1: Validation scheme for training algorithms. Data was split into training and 
validation subsets (ratio 2:1, SZ:HC ratio retained). The validation data was set aside, and 
the training subset was further divided into training and testing groups to tune the model 
parameters using 10-fold cross-validation. The tuned models were then applied to the 
validation set. Performance is reported for both training and validation groups.  
 
Figure(s)
Table 1: Studies using structural MR imaging to classify schizophrenia patients and healthy controls included in Kambeitz et al., 2015 
Study Sample Method Validation Metric Feature Reduction Accuracy 
Bansal et al., 2012 65 HC, 40 SZ Hierarchical 
Clustering 
10 rounds of 
split-half & 
LOOCV 
Surface morphology of 





Borgwardt et al., 2012 22 HC, 23 FEP SVM (non-linear) Nested cross-
validation 
RAVENS (GM) Multivariate filter 
method & PCA 
86.7% 





Fan et al., 2007 Female Sample: 38 HC, 
23 SZ 
Male Sample: 41 HC, 
46 SZ 





Greenstein et al., 2012 99 HC, 98 SZ Random Forests Out-of-bag (33% 
left out at each 
tree) 
74 ROIs (cortical and 
subcortical volumes) 
None 73.6% 
Karageorgiou et al., 
2011 












Kawasaki et al., 2007 Training Sample: 30 
HC, 30 SZ 
Held-out Group: 16 









Nakamura et al., 2004 Female Sample: 22 HC, 
27 SZ 
Male Sample: 25 HC, 
30 SZ 








Nieuwenhuis et al., 
2012 
Training Sample: 111 
HC, 128 SZ 
Validation Sample: 122 
HC, 155 SZ 




VBM (GM) Image downsampling, 
selection of top 10% 
ranked discriminatory 





Ota et al., 2012 Female Sample: 128 
HC, 61 SZ 
LDA Held-out group 
(23 HC, 23 SZ) 
VBM (GM & CSF) ROIs & stepwise 
variable addition 
71.7% 
Petterson-Yeo et al., 
2013 
19 HC, 19 FEP SVM (linear) LOOCV GM None 63.2% 
Sun et al., 2009 36 HC, 36 ROS Sparse Multinomial 
Logistic Regression 
LOOCV Surface-based GM 
densities 
None 86.1% 
Santos et al., 2010 25 HC, 43 SZ LDA LOOCV Voxel intensities PCA 66.2% 
Takayanagi et al., 
2010 
Male Sample: 24 HC, 
17 FEP 
Female Sample: 24 HC, 
17 FEP 





Takayanagi et al., 
2011 
Male Sample: 22 HC, 
29 FEP 
Female Sample: 18 HC, 
23 FEP 











Yushkevich et al., 
2005 
46 HC, 46 SZ SVM LOOCV Select ROIs LOOCV-based feature 
selection 
70.7% 
Zanetti et al., 2013 62 HC, 62 FE SVM (non-linear) LOOCV RAVENS (GM, WM, 
CSF) 
COMPARE 73.4% 
Sample: FEP: First-Episode Psychosis; HC: Healthy Control; ROS: Recent-Onset Schizophrenia; SZ: Schizophrenia 
Method: LDA: Linear Discriminant Analysis; SVM: Support Vector Machine 
Validation: LOOCV: Leave-One-Out Cross-Validation 
Metric: CSF: Cerebrospinal Fluid GM: Grey Matter; RAVENS: Regional Analysis of Volumes Examined in Normalized Space; ROI: 
Region of Interest; VBM: Voxel-Based Morphometry; WM: White Matter 
Feature Reduction: COMPARE: Classification of Morphological Patterns using Adaptive Regional Elements; PCA: Principal 
Component Analysis 
Table 2: Summary of study design. 42 combinations were studied in total across two 
validation schemes. VBM = voxel-based morphometry; GM = grey matter, RAVENS = 
Regional Analysis of Volumes in Normalized Space (Davatzikos et al., 2001); LR = 
logistic regression; LDA = linear discriminant analysis; SVM = support vector machine; 
COMPARE = Classification of Morphological Patterns using Recursive Feature 
Elimination (Fan et al., 2007).   
Dataset Feature Set Classification Method Validation Scheme 
CAMH VBM (GM) LR 10-fold cross-val 
NUSDAST RAVENS (GM) LDA Held-out subset 
INNN Cortical thickness Linear SVM  
  Non-linear SVM  
  COMPARE  
 
Table(s)
Table 3: Demographic characteristics of all datasets 
 CAMH (1.5T) NUSDAST (1.5T) INNN (3T) 
Demographic Schizophrenia 
Patients 




FEP Patients Healthy 
Controls 
  (n=88) (n=103) (n=91) (n=67) (n=50) (n=50) 
  Mean SD Mean SD Mean SD Mean SD Mean SD Mean SD 
Age 36.6 12.4 35.2 12.4 32.1 12.2 25.8 9.80 25.8 7.35 23.8 4.79 
Education (years)  13.3a 2.33 15.5a 1.91 12.0a 2.00 13.9a 2.56 11.9a 3.26 15.6a 2.57 
Parental Education 
(years) 
12.7a 7.00 17.0a 4.37 13.8 3.12 14.3 2.66 9.58a 5.19 13.9a 3.01 
WTAR (IQ)  109a 15.7 117a 8.27 -- -- -- -- -- -- -- -- 
MMSE 28.9a 1.75 29.4a 0.833 -- -- -- -- -- -- -- -- 
CIRS 1.55a 0.811 0.824a 0.639 -- -- -- -- -- -- -- -- 
Age of onset 24.0 6.78 NA NA -- -- NA NA 24.7 7.51 NA NA 
Illness Duration (weeks) 658 641 NA NA -- -- NA NA 35.1 56.0 NA NA 
PANSS                 
Positive 14.18 5.98 NA NA -- -- NA NA 23.9 4.97 NA NA 
Negative 14.27 6.11 NA NA -- -- NA NA 24.3 5.83 NA NA 
General 25.33 6.99 NA NA -- -- NA NA 49.4 8.61 NA NA 
SAPS -- -- NA NA 22.4 16.8 NA NA -- -- NA NA 
SANS -- -- NA NA 30.5 17.3 NA NA -- -- NA NA 
  N N N N N N 
Diagnosis 60 SZ 27 SA NA -- -- NA 11 BPD/ 18 
SFD/ 21 SZ 
NA 
Sex 58 M 30 F 56 M 46 F 61 M 30 F 39 M 28 F 31 M 19 F 32 M 18 F 
Handedness 80 R 6 L  89 R 7 L 80 R 9 L 58 R 9 L 50 R 50 R 
a significant at p<0.05 between diagnostic groups 
Abbreviations: SD = Standard Deviation; WTAR = Weschler Test for Adult Reading; 
MMSE = Mini-Mental State Exam; CIRS = Cumulative Illness Rating Scale; PANSS =  
Positive And Negative Syndrome Scale; SAPS = Scale for Assessment of Positive 
Symptoms; SANS = Scale for Assessment of Negative Symptoms; SZ = Schizophrenia; 
SA= Schizoaffective Disorder; BPD = Bipolar Disorder; SFD = Schizophreniform 
Disorder 
Table(s)
Table 4: All training set results (using 10-fold cross-validation). Results are reported as % 
accuracy (averaged across all folds).  
 Modulated VBM RAVENS Maps Cortical Thickness 
  CAMH NUSDAST INNN CAMH NUSDAST INNN CAMH NUSDAST INNN 
LR 60.0b 57.4a 62.1a 60.8c 66.0c 70.0c 50.8 68.8c 57.6 
SVM (linear) 55.0a 54.3 56.1 51.7 55.3a 66.7c 60.2b 71.9c 60.6a 
SVM (RBF) 61.7c 64.2b 63.8b 63.3c 60.9b 69.8c 68.0c 68.8c 64.1b 
LDA 59.2b 56.4a 57.6a 59.2b 57.5a 56.1 55.5a 65.6c 57.6a 
COMPARE 63.3c 71.3c 71.2c 55.8a 50.0 50.0 -- -- -- 





Table 5: All validation set results. Results are reported as % accuracy (sensitivity/specificity).  
 Modulated VBM RAVENS Maps Cortical Thickness 
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